Chayce David Clark Nu Skin Enterprises, Inc. (NUS) insider trading activity

Chayce David Clark is EVP and General Counsel of NU SKIN ENTERPRISES, INC.. Currently has a direct ownership of 253,345 shares of NUS, which is worth approximately $1.94 Million. The most recent transaction as insider was on Feb 26, 2025, when has been sold 113,196 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 253K

61.37% 3M change

60.17% 12M change

Total Value Held $1.94 Million

Chayce David Clark Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 26 2025	BUY Grant, award, or other acquisition	-	113,196 Added 30.88%	253,345 Class A Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$107,556 $7.56 p/Share	14,227 Reduced 9.22%	140,149 Class A Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	6,451 Added 4.01%	154,376 Class A Common Stock
Dec 20 2024	SELL Payment of exercise price or tax liability	$59,862 $6.6 p/Share	9,070 Reduced 5.78%	147,925 Class A Common Stock
Aug 01 2024	SELL Payment of exercise price or tax liability	$2,255 $10.95 p/Share	206 Reduced 0.13%	156,995 Class A Common Stock
Jun 05 2024	SELL Payment of exercise price or tax liability	$13,119 $13.47 p/Share	974 Reduced 0.62%	157,201 Class A Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	69,116 Added 30.41%	158,175 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$77,198 $13.82 p/Share	5,586 Reduced 5.9%	89,059 Class A Common Stock
Feb 13 2024	BUY Grant, award, or other acquisition	-	3,522 Added 3.59%	94,645 Class A Common Stock
Dec 20 2023	SELL Payment of exercise price or tax liability	$174,960 $19.29 p/Share	9,070 Reduced 9.05%	91,123 Class A Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	$6,126 $29.74 p/Share	206 Reduced 0.21%	100,193 Class A Common Stock
Jun 05 2023	SELL Payment of exercise price or tax liability	$33,031 $33.74 p/Share	979 Reduced 0.97%	100,399 Class A Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	18,090 Added 15.14%	101,378 Class A Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$59,130 $45.38 p/Share	1,303 Reduced 1.54%	83,288 Class A Common Stock
Dec 20 2022	BUY Grant, award, or other acquisition	-	61,836 Added 42.23%	84,591 Class A Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$6,105 $44.56 p/Share	137 Reduced 0.6%	22,755 Class A Common Stock
Jun 05 2022	SELL Payment of exercise price or tax liability	$30,445 $46.91 p/Share	649 Reduced 2.76%	22,892 Class A Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	8,430 Added 26.37%	23,541 Class A Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$42,947 $49.65 p/Share	865 Reduced 5.41%	15,111 Class A Common Stock
Aug 01 2021	BUY Grant, award, or other acquisition	-	1,863 Added 10.44%	15,976 Class A Common Stock

CDC

Chayce David Clark

EVP and General Counsel

Provo, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUS shares.

Notify only if

Value

Insider Trading

Get notified when an Nu Skin Enterprises, Inc. insider buys or sells NUS shares.

Notify only if

Operation

Value

Type

News

Receive news related to NU SKIN ENTERPRISES, INC.

Track Activities on NUS

Account